This site uses cookies. By using this site you agree to receiving cookies. View Policy.

TC BioPharm is a world-leading immunotherapy company that has seen positive results in its latest clinical cancer trial. They are now looking to advance those trials as well as extend their IP protected technology to a COVID-19 therapy, having recently received regulatory approval for a Phase I trial.

  • Amount raised (£)

    £1,751,820

  • Company number

    SC453579

  • Incorporation date

    01/07/2013

  • Total investors

    676

Details

  • Company number

    SC453579

  • Incorporation date

    01/07/2013

  • Company status

    Active

  • Industry type

    Research and experimental development on biotechnology

  • Number of current appointments

    7

Maxim 1 2 Parklands Way
Holytown
Motherwell
Lanarkshire
ML1 4WR

Crowdcube Funding History

Date Amount No. of Investors
02/12/2020 £1,751,820 676 View
Date Description Type
05/10/2020

Statement of capital following an allotment of shares on 2020-08-25

PDF
08/09/2020

Satisfaction of charge SC4535790001 in full

PDF
17/08/2020

Confirmation statement made on 2020-07-01 with updates

PDF

People

Name Role Appointed Nationality
RINTOUL, Toby Secretary 18/08/2018
CLARK, Alan George Director 16/07/2016 British
LEEK, Michael David, Dr Director 13/07/2013 British
MINOURA, Kimihito Director 19/10/2019 Japanese
PORTER, Lorraine Christie Director 15/07/2015 British
SCOTT, Angela Rita Rafaella Director 18/12/2018 British
THORP, Martin Director 16/03/2016 British